Nautilus Biotechnology Stock Price Prediction
| NAUT Stock | USD 2.34 0.09 3.70% |
Oversold Vs Overbought
47
Oversold | Overbought |
Nautilus Biotechnology stock price prediction is an act of determining the future value of Nautilus Biotechnology shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Nautilus Biotechnology's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Nautilus Biotechnology and does not consider all of the tangible or intangible factors available from Nautilus Biotechnology's fundamental data. We analyze noise-free headlines and recent hype associated with Nautilus Biotechnology, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Nautilus Biotechnology's stock price prediction:EPS Estimate Next Quarter (0.15) | EPS Estimate Current Year (0.74) | EPS Estimate Next Year (0.83) | Wall Street Target Price 4.25 | EPS Estimate Current Quarter (0.14) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Nautilus Biotechnology based on different types of headlines from major news networks to social media. The Nautilus stock price prediction module provides an analysis of price elasticity to changes in media outlook on Nautilus Biotechnology over a specific investment horizon. Using Nautilus Biotechnology hype-based prediction, you can estimate the value of Nautilus Biotechnology from the perspective of Nautilus Biotechnology response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Nautilus Biotechnology using Nautilus Biotechnology's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Nautilus using crowd psychology based on the activity and movement of Nautilus Biotechnology's stock price.
Nautilus Biotechnology Implied Volatility | 420.83 |
Nautilus Biotechnology's implied volatility exposes the market's sentiment of Nautilus Biotechnology stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Nautilus Biotechnology's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Nautilus Biotechnology stock will not fluctuate a lot when Nautilus Biotechnology's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Nautilus Biotechnology. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Nautilus Biotechnology to buy its stock at a price that has no basis in reality. In that case, they are not buying Nautilus because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Nautilus Biotechnology after-hype prediction price | USD 2.32 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Nautilus |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Nautilus Biotechnology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Nautilus Biotechnology After-Hype Price Prediction Density Analysis
As far as predicting the price of Nautilus Biotechnology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Nautilus Biotechnology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Nautilus Biotechnology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Nautilus Biotechnology Estimiated After-Hype Price Volatility
In the context of predicting Nautilus Biotechnology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Nautilus Biotechnology's historical news coverage. Nautilus Biotechnology's after-hype downside and upside margins for the prediction period are 0.12 and 6.94, respectively. We have considered Nautilus Biotechnology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Nautilus Biotechnology is very risky at this time. Analysis and calculation of next after-hype price of Nautilus Biotechnology is based on 3 months time horizon.
Nautilus Biotechnology Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Nautilus Biotechnology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nautilus Biotechnology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Nautilus Biotechnology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.33 | 4.62 | 0.02 | 0.08 | 10 Events / Month | 13 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2.34 | 2.32 | 0.85 |
|
Nautilus Biotechnology Hype Timeline
Nautilus Biotechnology is now traded for 2.34. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of -0.08. Nautilus is anticipated to decline in value after the next headline, with the price expected to drop to 2.32. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.85%, whereas the daily expected return is now at -0.33%. The volatility of related hype on Nautilus Biotechnology is about 1795.09%, with the expected price after the next announcement by competition of 2.26. About 34.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.16. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Nautilus Biotechnology recorded a loss per share of 0.51. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 10 days. Check out Nautilus Biotechnology Basic Forecasting Models to cross-verify your projections.Nautilus Biotechnology Related Hype Analysis
Having access to credible news sources related to Nautilus Biotechnology's direct competition is more important than ever and may enhance your ability to predict Nautilus Biotechnology's future price movements. Getting to know how Nautilus Biotechnology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Nautilus Biotechnology may potentially react to the hype associated with one of its peers.
Nautilus Biotechnology Additional Predictive Modules
Most predictive techniques to examine Nautilus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Nautilus using various technical indicators. When you analyze Nautilus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Nautilus Biotechnology Predictive Indicators
The successful prediction of Nautilus Biotechnology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Nautilus Biotechnology, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Nautilus Biotechnology based on analysis of Nautilus Biotechnology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Nautilus Biotechnology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Nautilus Biotechnology's related companies. Story Coverage note for Nautilus Biotechnology
The number of cover stories for Nautilus Biotechnology depends on current market conditions and Nautilus Biotechnology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Nautilus Biotechnology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Nautilus Biotechnology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Nautilus Biotechnology Short Properties
Nautilus Biotechnology's future price predictability will typically decrease when Nautilus Biotechnology's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Nautilus Biotechnology often depends not only on the future outlook of the potential Nautilus Biotechnology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Nautilus Biotechnology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 124.9 M | |
| Cash And Short Term Investments | 173.4 M |
Check out Nautilus Biotechnology Basic Forecasting Models to cross-verify your projections. For more information on how to buy Nautilus Stock please use our How to Invest in Nautilus Biotechnology guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Nautilus Stock analysis
When running Nautilus Biotechnology's price analysis, check to measure Nautilus Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nautilus Biotechnology is operating at the current time. Most of Nautilus Biotechnology's value examination focuses on studying past and present price action to predict the probability of Nautilus Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nautilus Biotechnology's price. Additionally, you may evaluate how the addition of Nautilus Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
Is Nautilus Biotechnology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nautilus Biotechnology. If investors know Nautilus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nautilus Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.51) | Return On Assets (0.15) | Return On Equity (0.22) |
The market value of Nautilus Biotechnology is measured differently than its book value, which is the value of Nautilus that is recorded on the company's balance sheet. Investors also form their own opinion of Nautilus Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Nautilus Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nautilus Biotechnology's market value can be influenced by many factors that don't directly affect Nautilus Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nautilus Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nautilus Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nautilus Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.